HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pediatric nonalcoholic fatty liver disease.

Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the pediatric population. Increased recognition of this form of liver disease parallels the dramatic rise in childhood and adolescent obesity over the past 2 decades. Like adults, most children with NAFLD are obese, and comorbidities include insulin resistance, hypertension, and dyslipidemia. Unfortunately, pediatric NAFLD is not always a benign condition, with some children progressing to hepatic fibrosis and even cirrhosis in severe cases. The etiology of nonalcoholic steatohepatitis is not yet fully understood; however, hepatic steatosis in the context of insulin resistance and increased oxidative stress may lead to progressive disease. Although physical examination, laboratory evaluation, and radiographic findings provide clues to the potential presence of fatty liver disease, liver biopsy remains the gold standard for diagnosis. Lifestyle modification, including slow and steady weight loss, improved dietary habits, and increased daily, aerobic physical activity, remains the first-line approach in treating pediatric fatty liver disease. Antioxidant pharmacologic therapy such as use of vitamin E has shown some benefit in patients with biopsy-proven steatohepatitis. Nutrition plays an essential role not only in the development of fatty liver disease but also potentially in the treatment and prevention of progression to more severe disease.
AuthorsMolly A Bozic, Girish Subbarao, Jean P Molleston
JournalNutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition (Nutr Clin Pract) Vol. 28 Issue 4 Pg. 448-58 (Aug 2013) ISSN: 1941-2452 [Electronic] United States
PMID23917437 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
Chemical References
  • Antioxidants
Topics
  • Antioxidants (therapeutic use)
  • Diet
  • End Stage Liver Disease (etiology, prevention & control)
  • Fatty Liver (complications, diagnosis, pathology, therapy)
  • Female
  • Humans
  • Liver (pathology)
  • Liver Cirrhosis (etiology, prevention & control)
  • Male
  • Non-alcoholic Fatty Liver Disease
  • Pediatric Obesity (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: